Novonesis Leads Europe's Stoxx 600 on Sales Beat, Guidance Raise

3-line summary

• Novonesis, which develops enzymes, probiotics and other biological products, led gains on Europe's Stoxx 600 after posting organic sales growth ahead of consensus estimates and raising guidance, according to the Wall Street Journal.

This summary is our own processing of the source article; see the source link below for full context.